X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Solifenacin is an anticholinergic for overactive bladder that targets the bladder receptors more strongly than older substances in its group. It works about as well, but is usually better tolerated and only needs to be taken once a day. Two points are especially typical of solifenacin: the possible prolongation of the QT interval of the heart, and its breakdown via the enzyme CYP3A4, which is inhibited by grapefruit and certain medicines.
See more detail.gif)
Reminders, tolerability and interactions in one place — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Solifenacin (usually as solifenacin succinate) |
| ATC code | G04BD08 |
| Drug class | Anticholinergic (muscarinic receptor antagonist) with a preference for M3 receptors |
| Dosage forms | Film-coated tablets, usually 5 mg and 10 mg; also as an oral suspension |
| Half-life | Long, in the order of 45 to 70 hours — the basis for once-daily dosing |
| Maximum daily dose | According to the SmPC, usually 10 mg daily; lower with impaired kidney or liver function |
| Onset of effect | First effects after about a week, assessment after about 4 to 12 weeks |
| Prescription status | Prescription-only medicine |
| Notable feature | More bladder-selective than older anticholinergics; broken down via CYP3A4, possible QT prolongation |
Anticholinergics block muscarinic receptors — the docking sites for the messenger substance acetylcholine. As a result, the bladder muscle contracts involuntarily less often, and the bladder holds more before the urge to urinate sets in. So far, that applies to every substance in this group.¹
The difference lies in the detail. Muscarinic receptors come in several subtypes. Bladder contraction is driven mainly by the M3 type; in the salivary glands, the eye, the heart and the brain, other subtypes and other tissue properties play a major role. Solifenacin binds preferentially to M3 receptors and also reaches the brain less readily than smaller, more fat-soluble substances. That is exactly what explains its milder profile.
Solifenacin is used for overactive bladder (also known as irritable bladder) with a sudden, compelling urge to urinate, frequent trips to the toilet and, where applicable, urge incontinence — that is, involuntary leakage of urine at the moment of urgency. It treats the symptoms: it dampens the complaints for as long as it is taken and does not cure the cause.
The following information describes the usual approach according to the SmPC (Summary of Product Characteristics). It is not a dosing instruction — your dose is set by the treating practice.
brite takes care of the reminder, and you can see the history at your next appointment.
The side-effect profile follows the same pattern as with all anticholinergics — only in a milder form. Two complaints clearly top the list.
Like all anticholinergics, solifenacin is not suitable in untreated angle-closure glaucoma, urinary retention, severe gastrointestinal disease with obstruction of the bowel, or myasthenia gravis. These diagnoses need to be on the table before treatment starts.
The QT interval is a section of the ECG. It describes how long the heart's ventricles need to recover electrically after each beat. If this phase becomes too long, a dangerous heart rhythm disorder can develop in rare cases — known as torsade de pointes.¹
Solifenacin can prolong the QT interval in a dose-dependent way. For most people with a healthy heart, this has no practical significance. It becomes critical when several factors come together — and that is precisely the point this article wants to highlight: the risk almost never comes from solifenacin alone, but from combinations.
In practice, this does not mean these combinations are forbidden. It means they have to be known. If you are prescribed solifenacin, you should disclose your complete medication list — including preparations prescribed by another practice. Depending on the situation, an ECG is recorded, potassium and magnesium levels are checked (understanding blood values) or one of the two substances is swapped.
There is, incidentally, no warning sign you can feel: a prolonged QT interval does not hurt. What may stand out are heart palpitations, a sudden dizzy spell or a brief loss of consciousness — events like these always need to be investigated and should not be put down to “circulation”.
In the liver, solifenacin is broken down mainly by the enzyme CYP3A4. This enzyme is one of the body's most important breakdown routes — and it can be blocked. If it is inhibited, the drug builds up: the blood level rises, and with it dry mouth, constipation and the risk of QT prolongation.
On the medication side, it is mainly strong CYP3A4 inhibitors: certain antifungals used against fungal infections, macrolide antibiotics such as clarithromycin, and some HIV medicines. When they are used at the same time, the solifenacin dose is usually capped or treatment is temporarily adjusted. The reverse case also exists: strong CYP3A4 inducers such as St John's wort or certain antiepileptics speed up the breakdown and can weaken the effect.
The tricky part is the everyday situation. An antibiotic for sinusitis is prescribed for seven days — by a different practice that knows nothing about the bladder tablet. Short in-between prescriptions like this are the typical trigger. A complete, up-to-date medication plan that you show everywhere prevents this more reliably than any amount of studying package leaflets.
| Combination | Consequence | What to do |
|---|---|---|
| Strong CYP3A4 inhibitors (antifungals, clarithromycin, certain HIV medicines) | Solifenacin level rises, more side effects | Clarify a dose cap or an alternative with your doctor |
| Grapefruit, pomelo, bitter orange | The same effect via the gut wall | Avoid during treatment |
| QT-prolonging medicines, e.g. citalopram | Additive QT prolongation | Check the combination specifically, ECG if needed |
| Other medicines with anticholinergic effects | Cumulative dry mouth, constipation, confusion | Have the total burden assessed by a doctor |
| Water tablets (diuretics), laxatives with potassium loss | Low potassium increases the QT risk | Monitor potassium and magnesium |
| Metoclopramide and other agents that stimulate gut motility | Opposing effects, both become weaker | Question the purpose of the combination |
| Alcohol | Increased tiredness; alcohol also irritates the bladder | Hold back, see medications and alcohol |
The practical rule is simple: every new prescription and every over-the-counter product should be checked against your existing list before it is added — that is what the interaction check is for.
Solifenacin is partly broken down by the liver and partly excreted by the kidneys. Both organs therefore set a limit on the dose — and for this substance that limit is laid down more specifically than for some others.
What matters is that kidney function is not a fixed value. It changes with age, dehydration, feverish infections and new medicines. A dose that suited you two years ago can be too high today. What applies in general is set out in the guide medications for kidney and liver disease.
Solifenacin is considered the better-tolerated choice among the anticholinergics — it reaches the brain less readily than older, highly fat-soluble substances and triggers confusion less often. That is a real advantage, especially compared with oxybutynin. But it is no reason to tick the subject off.
Because the decisive factor in older age is not the individual preparation but the total anticholinergic burden: the sum of all the medicines that have even a weak anticholinergic effect. Older antidepressants, some antipsychotics, older antihistamines, certain stomach and bladder medicines — each unremarkable on its own, but together enough to impair memory, attention and steadiness on your feet.
On top of that, in older age there is the second point from section 5: older people more often take medicines that affect the QT interval and more often have low potassium levels caused by water tablets. Together, these make checking combinations more important than in younger patients.
Honesty pays off here, because unrealistic expectations are the most common reason for disappointment and for stopping treatment.
In overactive bladder, anticholinergics on average reduce the number of trips to the toilet and of urgency episodes, and they reduce the number of incontinence episodes. Very few people become completely free of symptoms. The effect is real and noticeable in everyday life for many — but it is gradual: “I never make it in time” becomes “I usually make it”, not “I don't notice anything any more”.²,³
And the second part of the truth: the medicine is only half the treatment. Bladder training, regulated drinking habits and pelvic floor training come first in overactive bladder and work better together with the medicine than either does on its own.³ Fixed toilet times instead of going whenever the urge strikes, slowly lengthened intervals, waiting for urge waves to pass while standing still instead of rushing off — these are the building blocks that turn a moderate drug effect into a noticeable gain in everyday life. Urinary incontinence is a medical problem like any other and no reason to avoid the subject.⁴
In many cases, yes. Solifenacin binds preferentially to the receptors of the bladder muscle and therefore causes, on average, less frequent and milder dry mouth than older anticholinergics. That does not make it disappear — it remains the most common side effect, and it increases at the higher dose step. If the lower strength works well enough, it is therefore often the better choice. Tell your practice specifically how much the dryness bothers you: therapeutically, there is a big difference between “annoying when I talk” and “it wakes me up at night”.
This refers to the possible prolongation of the QT interval. For people with a healthy heart, normal potassium and magnesium levels and no other QT-prolonging medicines, it is usually not a practical problem. It becomes relevant with combinations — for instance with certain antidepressants, antipsychotics or macrolide antibiotics — and with known heart rhythm disorders. The right response is therefore not worry but transparency: show your complete medication list, mention any existing heart conditions and, if you faint or have attacks of a racing heart, get medical help immediately.
Better not while you are being treated with solifenacin. Grapefruit inhibits the enzyme that breaks down the drug, and it does so persistently — leaving a gap before or after the tablet does not solve the problem. The level can rise as a result, which intensifies dry mouth, constipation and the QT risk. Pomelo and bitter orange are affected too. Other citrus fruits such as oranges, mandarins and lemons, on the other hand, you can eat and drink as normal.
The interaction check recognises CYP3A4 inhibitors and QT combinations.
Medication reminders, an interaction check and your bladder history in one place. Free.
Create medication plan